Skip to main content

Table 3 The number of patients with the adverse effects in the N-Acetylcysteine + risperidone group and Placebo+risperidone group

From: A randomized double blind placebo controlled clinical trial of N-Acetylcysteine added to risperidone for treating autistic disorders

Adverse effect

N-Acetylcysteine + risperidone group

Placebo+risperidone group

Number

Percent

Number

Percent

Daytime drowsiness

4

12.9

2

6.5

Morning drowsiness

1

3.2

0

0

Stiffness

2

6.5

0

0

Slowed movement

2

6.5

0

0

Decreased Appetite

1

3.2

-

0

Fatigue

4

12.9

4

3.2

Constipation

5

16.1

1

3.2

Increased appetite

5

16.1

3

9.7

Decreased appetite

2

6.5

1

3.2

Diarrhea

0

0

1

3.2

Tremor

2

6.5

0

0

Abdominal pain

1

3.2

0

0

Nervousness

4

12.9

0

0

Itches

1

3.2

1

3.2

Restlessness

2

6.5

2

6.5

Twitches

1

3.2

0

0

Blurred vision

1

3.2

0

0

Urinary retention

0

0

0

0

Dizziness

0

0

0

0

Skin rash

0

0

0

0

Itches

0

0

0

0

Dry mouth

0

0

0

0

Swallowing difficulty

0

0

0

0

Seizure

0

0

0

0